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ing. If done early in the course of the work-up, CE short-
ens the time to diagnosis and spares a number of alterna-
tive investigations with lower diagnostic yield. Taken 
together this seems appealing to doctors. 
 A somewhat puzzling fact is that, in the majority of 
studies done so far for established indications, in only a 
small proportion of patients does CE have a real impact 
on the clinical outcome – even at a higher diagnostic 
yield. This clearly argues in favor of focused diagnostic 
strategies when considering CE for a work-up. In a way 
this contrasts with attempts to look for additional indica-
tions for CE – sometimes probably encouraged by the 
manufacturer with the aim to simply sell more CE de-
vices. From the data presented so far we have no reason 
to believe that CE is of any help in the differential diag-
nosis of diffuse abdominal pain. Data presented from 
studies in patients with Crohn’s disease and polyposis 
syndromes seem interesting but have not really changed 
the diagnostic protocols. Here, modern enteroclysis tech-
niques and double-balloon endoscopy are strong compet-
itors. 
 In this issue of  Digestion , Peter et al. present an analy-
sis of the frequency of lesions picked up in the esophagus 
and the stomach by CE compared to previous esophago-
gastroscopy (EGD) fi ndings. Although, the study has 
 Since the fi rst upper gastrointestinal (GI) endoscopy 
was performed in 1881 by Mikulicz-Radecki, marked ad-
vances have been achieved in our ability to view the GI 
tract. The introduction of fl exible endoscopes facilitated 
intubation of deeper portions of the GI tract. However, 
for several decades endoscopy of the small bowel was 
rather limited to only a small portion of the closest upper 
bowel or tainted with a higher risk of complications when 
performing our so-called push endoscopies. Recently, a 
noninvasive method for examination of the small bowel 
has become available: capsule endoscopy (CE). The fi c-
tion of movie makers of simply swallowing a tablet-like 
instrument and thereby traveling through the GI tract 
seems realistic. In 2001 the Given Imaging System got 
FDA approval in the United States. Since its introduc-
tion, several studies have been performed which demon-
strated a certain superiority of this method above push 
endoscopy in the detection of lesions leading to obscure 
GI bleeding  [1, 2] . The data presented to date clearly un-
derline the usefulness of CE in the search for the sources 
of obscure GI bleeding. Pennazio et al.  [3] evaluated the 
sensitivity and specifi city of CE and the outcome after CE 
in 100 consecutive patients with obscure GI bleeding, and 
reported that the procedure helps in situations with ongo-
ing obscure-overt bleeding or with obscure-occult bleed-
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some pitfalls (e.g. retrospective analysis, no clinical out-
come reported, and the signifi cance of the reported fi nd-
ings is unclear), the authors nevertheless point out that 
signifi cant lesions were missed at EGD and only identi-
fi ed during CE. The capsule found more mucosal lesions 
in 9% of the patients in the stomach and in 8% in the 
esophagus. The authors call for a ‘re-look’ EGD in the 
diagnostic algorithm after a positive capsule fi nding and 
an earlier negative EGD. Clearly, we cannot safely rely 
on previous endoscopy reports produced by others (and 
unfortunately also by ourselves) when ongoing bleeding 
from the upper GI tract still prompts questions. Anyway, 
the question is well taken care of in the literature on how 
upper GI endoscopy in the search of bleeding sources cor-
relates with sensitivity and specifi city. 
 Another arising idea is worth discussion. Is it really 
possible that such a capsule rapidly rushing through the 
esophagus and fl ipping around the stomach will be of help 
in the future in the diagnostic routine of the upper GI 
tract? Presently, the design of the capsule is made for the 
journey through the small intestine. The capsule rapidly 
passes through the esophagus with an unpredictable 
transmission, thus limiting the number of pictures, in 
particular, of the distal esophagus. Technical advances 
may help when a second camera is built into the device, 
thereby increasing the number of pictures taken in a sec-
ond. The newly developed PillCam ESO Esophageal Cap-
sule has already been evaluated in patients with suspect-
ed esophageal disease  [4, 5] . The aim is clear: to develop 
CE as a screening instrument in refl ux patients. Up to 
now, a small pilot study has demonstrated that CE iden-
tifi ed all suspected lesions found in the endoscopy before. 
In this study, the mean time for the passage through the 
esophagus was 189  8 280 s. This seems unusually slow 
when compared to other reports and to our own experi-
ence. Another multicenter trial has compared the accu-
racy (specifi city, sensitivity, positive predictive value, 
and negative predictive value) of CE with EGD in pa-
tients with gastroesophageal refl ux disease. In this larger 
study 66 of 106 patients had positive endoscopic esopha-
geal fi ndings, CE identifi ed esophageal abnormalities in 
61 (sensitivity 92%; specifi city 95%). In contrast, several 
studies have raised substantial doubts after studying the 
distal esophagus by CE trying to fi nd an easy screening 
method for refl ux lesions  [6, 7] . In any case, even if the 
CE could reliably prove that the specifi city and sensitiv-
ity is nearly the same as for EGD, at least every patient 
with a pathologic result needs to get a EGD for biopsy
or treatment. Therefore, endoscopy rather than CE will
be offered to those with a clinical history of refl ux. A
combination of both will add signifi cant costs to the
work-up. 
 Will there be an indication for CE before EGD, for 
example CE as a general screening instrument to detect 
Barrett’s esophagus in a population of people older than 
45 years or to exclude cancer in those with dyspepsia? 
How will we then handle patients without pathology in 
the CE? Will we offer a consecutive endoscopy? 
 EGD still is the gold standard, safe in the hands of an 
experienced gastroenterologist and providing the oppor-
tunity for biopsies and treatment in the same procedure. 
Even if a previous EGD shows no abnormalities and seri-
ous concerns regarding the clinical situation remain, an-
other EGD should be performed rather than choosing CE. 
If the patient’s comfort is the issue, new ultra-thin naso-
gastric endoscopic instruments may offer an alternative. 
However, their potential needs to be evaluated. 
 Looking at the potential of CE in the stomach, things 
become even worse. One of the fi rst maneuvers every 
trainee in gastroenterology learns is to infl ate the stomach 
with air thereby improving the view. How can we expect 
that the fi ndings in CE are similar or even superior to 
conventional EGD in a fasted patient swallowing the cap-
sule? This technical problem may explain why when look-
ing up the term ‘capsule endoscopy’ in PubMed in the 
500 studies published from 2004 to 2005, not one points 
out that CE helps to detect lesions in the stomach. Still, 
Peter et al. make another point in this connection. They 
just tell us that it is worthwhile to ‘reintroduce the cord’ 
if CE hints a missed fi nding after EGD. This suggestion 
seems adequate and does not really imply a brighter fu-
ture for CE in the diagnostic work-up of the upper GI 
tract. For the small intestine, the double-balloon tech-
nique has the potential of becoming the standard of en-
teroscopy very likely replacing the conventional push 
 enteroscopy and intraoperative enteroscopy. It already 
appears to be superior to CE in the diagnosis of small-in-
testinal polyps, whereas the value for diagnosing GI 
bleeding of obscure origin is similar  [8, 9] . 
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